
Dendritic Cell Therapy for Lung Cancer Treatment in Germany
Imagine a treatment that boosts your own immune response to fight lung cancer with precision, causing virtually no side effects while you maintain your daily routine. Dendritic cell therapy offers this possibility to patients at any cancer stage, showing effectiveness rates of 50-65% across various cancer types.
With lung cancer affecting 226,650 new patients annually and survival rates ranging from 67% for early-stage to 12% for advanced disease, German clinics pioneer this personalized immunotherapy by creating individual DC vaccines for your tumor cells’ unique characteristics. Unlike…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.